Palmitic Acid

Palmitic Acid

SCHEMBL330778

CC=CC=CC=CCO.CCCCCCCCCCCCCCCC(=O)O

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FASN P49327 1/20 0.62
PPARG P37231 8/20 0.57
PPARD Q03181 8/20 0.57
PPARA Q07869 8/20 0.57
GPR84 Q9NQS5 7/20 0.57
HDAC11 Q96DB2 5/20 0.57
TSHR P16473 4/20 0.57
PTPN1 P18031 4/20 0.57
FABP4 P15090 4/20 0.57
HSD17B10 Q99714 3/20 0.57
ALDH1A1 P00352 2/20 0.57
TLR2 O60603 2/20 0.57
TDP1 Q9NUW8 2/20 0.57
ALOX15 P16050 2/20 0.57
KMT2A Q03164 2/20 0.57
FABP5 Q01469 2/20 0.57
SLC22A6 Q4U2R8 1/20 0.57
SLC22A8 Q8TCC7 1/20 0.57
MEN1 O00255 1/20 0.57
ESR1 P03372 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Palmitic Acid SCHEMBL3794496 1.00 FASN (0.62) FASNPPARGPPARDPPARAGPR84
Stearic Acid SCHEMBL27386843 0.98 FASN (0.64) FASNPPARGPPARDPPARAGPR84
Octanoic Acid SCHEMBL27876702 0.98 FASN (0.64) FASNPPARGPPARDPPARAGPR84
Dodecanoate SCHEMBL27663075 0.98 FASN (0.64) FASNPPARGPPARDPPARAGPR84
Stearic Acid SCHEMBL715877 0.98 FASN (0.64) FASNPPARGPPARDPPARAGPR84
Palmitic Acid SCHEMBL3250351 0.98 FASN (0.64) FASNPPARGPPARDPPARAGPR84
Dodecanoate SCHEMBL714246 0.98 FASN (0.64) FASNPPARGPPARDPPARAGPR84
Stearic Acid SCHEMBL1071278 0.98 FASN (0.64) FASNPPARGPPARDPPARAGPR84
Palmitic Acid SCHEMBL27532698 0.98 FASN (0.64) FASNPPARGPPARDPPARAGPR84
Dodecanoate SCHEMBL7947911 0.95 FASN (0.60) FASNPPARGPPARDPPARAGPR84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2373302-B1 THE USE OF COMPOUNDS TO INHIBIT 5alpha-REDUCTASE ENZYME ACTIVITY, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM GIULIANI SPA (IT) 2017-09-13 EP claimed
EP-2593097-B1 COMPOUNDS WITH A SKIN PIGMENTING ACTIVITY AND PHARMACEUTICAL OR COSMETIC COMPOSITIONS CONTAINING THEM GIULIANI SPA (IT) 2016-08-24 EP claimed
EP-2593097-A1 COMPOUNDS WITH A SKIN PIGMENTING ACTIVITY AND PHARMACEUTICAL OR COSMETIC COMPOSITIONS CONTAINING THEM Giuliani S.p.A. (IT) 2013-05-22 EP claimed
US-20130108564-A1 Compounds with a Skin Pigmenting Activity And Pharmaceutical or Cosmetic Compositions Containing Them GIULIANI S.P.A. (IT) 2013-05-02 US claimed
WO-2012007572-A1 COMPOUNDS WITH A SKIN PIGMENTING ACTIVITY AND PHARMACEUTICAL OR COSMETIC COMPOSITIONS CONTAINING THEM GIULIANI S.P.A. (IT) 2012-01-19 WO claimed
EP-2407163-A1 Compounds with a skin pigmenting activity and pharmaceutical or cosmetic compositions containing them Giuliani S.p.A. (IT) 2012-01-18 EP claimed
EP-2384191-B1 DIENE COMPOUNDS FOR USE IN HUMAN EPIDERMAL CELL REPAIR, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM GIULIANI SPA (IT) 2018-07-18 EP disclosed
EP-2373302-B1 THE USE OF COMPOUNDS TO INHIBIT 5alpha-REDUCTASE ENZYME ACTIVITY, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM GIULIANI SPA (IT) 2017-09-13 EP disclosed
US-9668984-B2 Use of compounds to inhibit 5 α-reductase enzyme activity, and pharmaceutical and cosmetic compostions containing them GIULIANI S.P.A. (IT) 2017-06-06 US disclosed
EP-2373302-A1 THE USE OF COMPOUNDS TO INHIBIT 5A-REDUCTASE ENZYME ACTIVITY, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM Giuliani S.p.A. (IT) 2011-10-12 EP disclosed
US-20110224298-A1 DIENE COMPOUNDS FOR USE IN HUMAN EPIDERMAL CELL REPAIR AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM GIULIANI S.P.A. (IT) 2011-09-15 US disclosed
US-20110218245-A1 USE OF COMPOUNDS TO INHIBIT 5A-REDUCTASE ENZYME ACTIVITY, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM GIULIANI S.P.A. (IT) 2011-09-08 US disclosed
WO-2010052329-A1 THE USE OF COMPOUNDS TO INHIBIT 5A-REDUCTASE ENZYME ACTIVITY, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM GIULIANI S.P.A. (IT) 2010-05-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110218245-A1 USE OF COMPOUNDS TO INHIBIT 5A-REDUCTASE ENZYME ACTIVITY, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM SRD5A1, CYP17A1, SRD5A2 FASN 126/4885PPARG 2214/4885PPARD 2872/4885
US-20110224298-A1 DIENE COMPOUNDS FOR USE IN HUMAN EPIDERMAL CELL REPAIR AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM KRT18, CKS2, MKI67 FASN 739/4885PPARG 1166/4885PPARD 1562/4885
US-20130108564-A1 Compounds with a Skin Pigmenting Activity And Pharmaceutical or Cosmetic Compositions Containing Them TYR, MC1R, HK1 FASN 1986/4885PPARG 3227/4885PPARD 3542/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.